Medication Use and Comorbidities Among Elderly as Compared to Younger Patients with Inflammatory Bowel Disease in the TARGET-IBD Cohort (ACG)

This is the ACG 2019 poster version of the elderly IBD medication use study (Row 7 manuscript, Row 21 DDW oral). Earliest conference presentation characterizing age-related medication use disparities in the TARGET-IBD cohort, with elderly patients receiving significantly more aminosalicylate monotherapy.

The TARGET-IBD registry was analyzed to compare medication use distributions across age categories at the ACG 2019 annual meeting, providing the first large-scale real-world characterization of this age-related treatment pattern gap.

Initial ACG 2019 dissemination of the elderly IBD medication use findings establishes the evidence foundation for subsequent publications and prescriber education on age-related treatment disparities, supporting the case for guideline revision regarding biologic access in elderly IBD patients.

First dissemination of elderly IBD medication use disparities for age-inclusive treatment guideline development, Initial real-world evidence of aminosalicylate overuse in elderly IBD for prescriber education, Evidence foundation for age-stratified IBD treatment advocacy and inclusive trial design